https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4498 Wed 11 Apr 2018 15:42:17 AEST ]]> Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38190 Tue 10 Aug 2021 16:00:40 AEST ]]> Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51479 Thu 07 Sep 2023 10:53:30 AEST ]]> Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13923 Sat 24 Mar 2018 08:24:50 AEDT ]]> Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26262 Sat 24 Mar 2018 07:40:14 AEDT ]]>